Bringing doctors together

or

A free, private network for verified physicians

Leading voices

Dr. Rebecca Miksad

GI Oncology · BMC

View

Dr. Colin Weekes

GI Oncology · MGH

View

Dr. Elizabeth Jaffee

GI Oncology · Johns Hopkins

View

Dr. Aparna Parikh

GI Oncology · PHS

View

Dr. Laura Vater

GI Oncology · IUSM

View

Dr. Kathleen Cooney

GU Oncology · Duke

View

Dr. Rebecca Shatsky

Breast Oncology · UCSD

View

Dr. Robert Bast

Breast Oncology · MD Anderson Cancer Center

View

Dr. Julia Close

General Oncology · UF

View

Dr. Sara Tolaney

Breast Oncology · Dana-Farber Cancer Institute

View
  • Discover your community

  • Stay current

  • A profile that represents you

  • Find your people

About RoonPrivacyTerms
    SMDr. Sarbajit Mukherjee

    Dr. Sarbajit Mukherjee

    Medical Oncology · Gastrointestinal Oncology
    Baptist Health Miami Cancer Institute
    sarbajit

    Research

    NCI9673 (Part B): ETCTN Randomized Phase II Study of Nivolumab With or Without Ipilimumab in Refractory, Metastatic Squamous Cell Carcinoma of the Anal Canal

    2026

    Via Journal of Clinical Oncology

    Research

    Prognostic immune markers in esophageal cancer patients managed with trimodal therapy

    2025

    Via Cancer Immunology, Immunotherapy

    Research

    Phase II Study of Nanoliposomal Irinotecan (Nal-IRI) with 5-Fluorouracil and Leucovorin in Refractory Advanced High-Grade Neuroendocrine Cancer of Gastroenteropancreatic (GEP) or Unknown Origin

    2025

    Via Cancers

    Research

    Camrelizumab combined with neoadjuvant docetaxel, oxaliplatin, and S1 as induction therapy for locally advanced esophageal squamous cell cancer: a real-world single-center cohort study

    2025

    Via Journal of Thoracic Disease

    Research

    CLO25-098: Impact of Bone Metastasis on Survival in Gastric and Gastroesophageal Junction Tumors

    2025

    Via Journal of the National Comprehensive Cancer Network

    Research

    Trifluridine/Tipiracil and Oxaliplatin as Induction Chemotherapy in Resectable Esophageal and Gastroesophageal Junction Adenocarcinoma: A Phase II Study

    2025

    Via Cancer Medicine

    Research

    Gastric Cancer, Version 2.2025, NCCN Clinical Practice Guidelines In Oncology

    2025

    Via Journal of the National Comprehensive Cancer Network

    Research

    Construction of a multigenic diagnostic, prognostic, and immune infiltration model with methylation-associated regulators in esophageal squamous cell carcinoma

    2025

    Via Journal of Thoracic Disease

    Research

    Phase II study of avelumab and trastuzumab with FOLFOX chemotherapy in previously untreated HER2-amplified metastatic gastroesophageal adenocarcinoma

    2025

    Via The Oncologist

    Research

    Survival in Patients with Colorectal Cancer and Isolated Brain Metastases: Temporal Trends and Prognostic Factors from the National Cancer Database (2010-2020)

    2025

    Via Cancers

    Research

    Proto-Oncogene HRAS Transcript Level and Overall Survival in Stages II and III Colorectal Cancer

    2025

    Via Cancer Medicine

    Research

    Effects of Neighborhood Deprivation Index on Survival in Gastroesophageal Adenocarcinoma

    2025

    Via Healthcare (Basel, Switzerland)

    Research

    The Efficacy and Safety of Beta-blockers and Immune Checkpoint Inhibitors in Patients with Cancer: A Systematic Review and Meta-analysis

    2025

    Via Targeted Oncology

    Research

    Cancer/testis antigen expression and co-expression patterns in Gastroesophageal Adenocarcinoma

    2024

    Via Research Square

    Research

    Effects of Immunotherapy on Quality-of-Life Outcomes in Patients with Gastroesophageal Cancers: A Meta-Analysis of Randomized Controlled Trials

    2024

    Via Healthcare (Basel, Switzerland)